KKR: S&P And CME Selling OSTTRA To KKR For $3.1 Billion

S&P Global and CME Group announced the signing of a definitive agreement to sell OSTTRA, a provider of post-trade solutions for the global OTC market, to investment funds managed by KKR. The terms of the deal for OSTTRA equaled total enterprise value at $3.1 billion, subject to customary purchase price adjustments. This amount will be divided evenly between S&P Global and CME Group pursuant to their 50/50 joint venture. The post S&P And CME Selling OSTTRA To KKR For $3.1 Billion appeared first on Pulse 2.0.